Ventriküler Septal Defekti Olan Hastada Chryseomonas luteola İle Oluşan İnfektif Endokardit:Vaka Sunumu

Abstract

Chryseomonas luteola: altta yatan bir hastalığı olan veya vücutta yabancı cisimle bağlantılı infeksiyonlara ve bakteriyemiye neden olan nadir etken mikroorganizmalardandır.Biz burada ventriküler septal defekti olan ve bilinen risk faktörlerinin herhangi birisini taşımayan hastada gelişen Chryseomonas luteola endokarditini sunduk. Anhatar Kelimeler: Chryseomonas luteola, Ventriküler septal defekt

Keywords

• -

An Unusual Infection of Chryseomonas luteola: Infective Endocarditis in a Patient with Ventricular Septal Defect

Abstract

Chryseomonas luteola has been recognized as an uncommon cause of bacteremia and infections in patients with underlying diseases or in association with foreign body. We presented an infective endocarditis in a patient with ventricular septal defect due to C. luteola in the absence of known risk factors. Key words: Chryseomonas luteola, Ventricular septal defect

Keywords

• Chryseomonas luteola, Ventricular septal defect

References

1. Gilardi GL, Hirschl S, Mandel M. Characteristics of yellow-pigmented nonfermentative bacilli (groups Ve-1 and Ve-2) encountered in clinical bacteriology. J Clin Microbiol 1975;1:384-9.
2. Kodama K, Kimura N, Komagata K. Two new species of Chryseomonas: C. oryzihabitans isolated from rice paddy and clinical specimens and C. luteola isolated from clinical specimens. Int J Syst Bacteriol 1985;35:467-74.
3. Kiska DL, Gilligan PH. Chryseomonas. In Murray PR, Baron EJO, Pfaller MA, Tenover FC, Yolken RH, editors, Manual of Clinical Microbiology, 7th Edition, Washington DC: American Society for Microbiology 1999:517-25.
4. Hogevik H, Olaison L, Andersson R, et al. Epidemiological aspects of infective endocarditis in urban population: A five year prospective study. Medicine 1995;74:324-39.
5. Sandre RM, Shafran SD.1996. Infective endocarditis: Review of 135 cases over 9 years. Clin Infect Dis 1996;22:276-86.
6. National Committee for Clinical Laboratory Standards (NCCLS). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7–A5.Wayne PA. 2000.
7. Berger SA, Siegman-Igra Y, Stadler J, Campus A. Group VE-1 septicemia. J Clin Microbiol 1983;17: 926–7.
8. Connor BJ, Kopecky RT, Frymoyer PA, Forbes BA. Recurrent Chryseomonas luteola (CDC Group Ve-1) peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol 1987;25:1113-4.

9. Engel JM, Alexander FS, Pachucki CT. Bacteremia caused by CDC group Ve-1 in previously healthy patient with granulomatous hepatitis. J Clin Microbiol 1987;25, 2023-4.
10. Freney J, Hansen W, Etienne J, Vandenesch F, Fleurette J. Postoperative infant septicemia caused by Chryseomonas luteola (CDC Group Ve-1) and Chryseomonas oryzihabitans (CDC Group Ve-2). J Clin Microbiol 1988;26:1241-3.
11. Ghosh, SK. A rare infection caused by Chryseomonas luteola. J Infect 2000;41:109-10.
12. Hawkins RE, Moriarty RA, Lewis DE, Oldfield EC. Serious infections involving the CDC group Ve bacteria Chryseomonas luteola and Flavimonas oryzihabitans. Rev Infect Dis 1991;13:257-60.
13. Kostman JR, Solomon F, Fekete T. Infection with Chryseomonas luteola (CDC group Ve-1) and Flavimonas oryzihabitans (CDC group Ve-2) in neurosurgical patients. Rev Infect Dis 1991;13:233–36.
14. Rastogi, S, Sperber SJ. Facial cellulitis and Chryseomonas luteola bacteremia in an otherwise healthy patient. Diagn Microbiol Infect Dis 1998;32:303-5.
15. Tsakris A, Hassapopoulou H, Skoura HL, Pournarasc S, Douboyasc J. Leg ulcer due to Pseudomanas luteola in a patient with sickle cell Disease. Diag Microbiol Infect Dis 2002;42:141-3.
16. O’Leary T, Fong IW. Prosthetic valve endocarditis caused by Group Ve-1 bacteria. J Clin Microbiol 1984;20:995.
17. Fass RJ, Barnishan J. In vitro susceptibilities of nonfermentative gram negative bacilli other than Chryseomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis 1980;2:841-53. For Correspondence: Dr.Gülay Yetkin
18. Inonu University Faculty of Medicine,
19. Department of Clinical Microbiology
20. E.mail :[e-mail]